Article{Bostyn2021,
	title = {Why a COVID IP Waiver Is not a Good Strategy},
	author = {Bostyn, S.},
	url = {https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3843327},
	year = {0517},
	date = {2021-05-17},
	keywords = {access to drugs, covid-19, data exclusivity, frontpage, intellectual property rights, Intellectuele eigendom, market exclusivity, pandemic, Patent law, patents, population health, SARS-CoV-2, trade secrets, TRIPS, vaccines, waiver, WTO},
}